Farmacosmo board confirms 2026 industrial plan targets after reviewing H1 revenue data

PUBT · 2d ago
Farmacosmo board confirms 2026 industrial plan targets after reviewing H1 revenue data
  • Farmacosmo’s board reviewed unaudited consolidated management figures for 1H26, confirming the group’s 2026 industrial plan targets.
  • Recorded 2Q26 group revenue of EUR 9.9 million, up 19% from 1Q26 revenue of EUR 8.4 million.
  • Reported 1H26 group revenue of EUR 18.4 million, down 10% from EUR 20.4 million a year earlier.
  • Reiterated focus on higher-margin retail channels, citing growth across group platforms in 2Q26 versus 1Q26.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Farmacosmo S.p.A. published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.